1-(piperidin-3-ylmethyl)-1H-1,2,3-triazole-4-carboxamide hydrochloride

Catalog No.: 
ACXKFC975
CAS No.: 
1713160-63-4
Molecular Formula: 
C9H16ClN5O
Molecular Weight: 
245.71
1-(piperidin-3-ylmethyl)-1H-1,2,3-triazole-4-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$135.00InquiryInquiry
100mg95%$193.00InquiryInquiry
250mg95%$267.00InquiryInquiry
1g95%$642.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(piperidin-3-ylmethyl)-1H-1,2,3-triazole-4-carboxamide hydrochloride
IUPAC Name1-(piperidin-3-ylmethyl)-1H-1,2,3-triazole-4-carboxamide hydrochloride
MDL No.MFCD27995665
Molecular FormulaC9H16ClN5O
Molecular Weight245.71
SMILESO=C(C1=CN(CC2CNCCC2)N=N1)N.[H]Cl
InChI KeyFYJSPUHJRUEAPF-UHFFFAOYSA-N
Synonym1-(piperidin-3-ylmethyl)-1H-1,2,3-triazole-4-carboxamide hydrochloride
CAS No.1713160-63-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACXKFC975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXSI016 route compound structure diagram
    ACKXSI0167341-96-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXKFC975 route product structure diagram
    ACXKFC9751713160-63-4
Inquiry

2. ACXKFC975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXKFC975 route product structure diagram
    ACXKFC9751713160-63-4
Inquiry

3. ACXKFC975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXKFC975 route product structure diagram
    ACXKFC9751713160-63-4
Inquiry

Comments (0)